Gara Jalqabaatti › Dhukkubaa Alzheimer › Arizona
Qorannoo klinikaalii Dhukkubaa Alzheimer Arizona keessatti
Qorannoo 23 Dhukkubaa Alzheimer f Arizona keessatti hirmaatuu jiru.
Magaalota Arizona keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Phoenix
- Clinical Site, Scottsdale
- Clinical Site, Tucson
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2609, Chandler
- Imaging Endpoints, Scottsdale
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Gilbert Neurology Partners - PLLC - Avacare, Gilbert
- Banner Alzheimer's Institute, Phoenix
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- TrialSphere Corp, Chandler
- HonorHealth Research Institute, Scottsdale
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Banner Alzheimer's Institute, Phoenix
- Barrow Neurological Institute, Phoenix
- Clinical Endpoints, Scottsdale
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Banner Alzheimer?s Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 90 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Imaging Endpoints, Scottsdale
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Chandler Clinical Trials, LLC, Chandler
- Local Institution - 2631, Chandler
- TrialSphere Corp, Chandler
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0040, Scottsdale
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06808984A Study of AMDX-2011P in Participants With Alzheimer's Disease
- Associated Retina Consultants, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT06514001The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Arizona, Tucson
Namoota walitti qabaa jira
Umuriin 55 hanga 85 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05988385Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Arizona State University, Phoenix
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 45 hanga 65 · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT05980052A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Banner Alzheimer's Institute, Phoenix
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Gilbert Neurology Partners/CCT Research, Gilbert
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Banner Alzheimers Institute, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Barrow Neurological Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Barrow Neurological Institute, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 25 hanga 55 · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT04165109A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Arizona State University, Phoenix
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT05877196Early-Stage Partner in Care Living Alone Plus
- Arizona State University, Phoenix
Namoota walitti qabaa jira
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06962111Repurposing Siponimod for Alzheimer's Disease
- St. Joseph's Hospital and Medical Center, Phoenix
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 04-Bit-2026 · NCT06639282A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Mayo Clinic Arizona, Scottsdale
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 50 hanga 95 · Saalaa hunda · Haaromfame 03-Gur-2026 · NCT06057909Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Banner Alzheimer's Institute, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 16-Mud-2025 · NCT02022943PROMIS and Mobility Evaluation in Sarcoma Patients
- Mayo Clinic, Phoenix
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Sad-2025 · NCT07227961Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.